Tissue penetration of antimicrobials: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 13: Line 13:
 
|β-lactamase inhibitors
 
|β-lactamase inhibitors
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|
 
|
Line 20: Line 20:
 
|[[ampicillin]]
 
|[[ampicillin]]
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|-
 
|-
 
| rowspan="4" |Cephalosporins
 
| rowspan="4" |Cephalosporins
 
|first-generation cephalosporins
 
|first-generation cephalosporins
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|-
 
|-
 
|second-generation cephalosporins
 
|second-generation cephalosporins
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|
 
|
Line 45: Line 45:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
|[[ceftazidime]]
 
|[[ceftazidime]]
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
| rowspan="2" |Cephamycins
 
| rowspan="2" |Cephamycins
 
|[[cephamycins]]
 
|[[cephamycins]]
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|
 
|
Line 67: Line 67:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|-
 
|-
 
|Carbapenems
 
|Carbapenems
Line 75: Line 75:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
! colspan="7" |Antibiotics: Non-β-Lactams
 
! colspan="7" |Antibiotics: Non-β-Lactams
Line 85: Line 85:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|-
 
|-
 
|Chloramphenicol
 
|Chloramphenicol
Line 93: Line 93:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
|Fluoroquinolones
 
|Fluoroquinolones
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –?
|–?
 
 
|
 
|
  +
| style="text-align:center" | +
| +
 
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
|Lincosamides
 
|Lincosamides
 
|[[clindamycin]]
 
|[[clindamycin]]
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
|Macrolides
 
|Macrolides
 
|[[macrolides]]
 
|[[macrolides]]
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|
 
|
 
|-
 
|-
 
|Nitrofurans
 
|Nitrofurans
 
|[[nitrofurantoin]]
 
|[[nitrofurantoin]]
  +
| style="text-align:center" | –
|–
 
  +
| style="text-align:center" | –
|–
 
  +
| style="text-align:center" | +
| +
 
  +
| style="text-align:center" | –
|–
 
  +
| style="text-align:center" | –
|–
 
 
|-
 
|-
 
|Nitroimidazoles
 
|Nitroimidazoles
Line 133: Line 133:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
|Rifamycins
 
|Rifamycins
Line 140: Line 140:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|
 
|
 
|-
 
|-
Line 148: Line 148:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
 
|-
 
|-
Line 154: Line 154:
 
|[[tetracyclines]]
 
|[[tetracyclines]]
 
|
 
|
  +
| style="text-align:center" | –
|–
 
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|
 
|
 
|-
 
|-
Line 164: Line 164:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|-
 
|-
 
! colspan="7" |Antifungals
 
! colspan="7" |Antifungals
Line 174: Line 174:
 
|
 
|
 
|
 
|
  +
| style="text-align:center" | +
| +
 
 
|}
 
|}
 
[[Category:Antimicrobials]]
 
[[Category:Antimicrobials]]

Revision as of 12:21, 24 August 2020

Class Antimicrobial Blood CNS Urine Prostate Necrotic
Antibiotics: β-Lactams
Penicillins β-lactamase inhibitors
ampicillin +
Cephalosporins first-generation cephalosporins
second-generation cephalosporins
cefepime +
ceftazidime + +
Cephamycins cephamycins
cefoxitin
Carbapenems imipenem +
Antibiotics: Non-β-Lactams
Aminoglycosides
Chloramphenicol chloramphenicol +
Fluoroquinolones –? + +
Lincosamides clindamycin +
Macrolides macrolides +
Nitrofurans nitrofurantoin +
Nitroimidazoles metronidazole +
Rifamycins rifampin +
Sulfonamides sulfamethoxazole
Tetracyclines tetracyclines +
doxycycline +
Antifungals
Azoles fluconazole +

References

  1. ^ nau2010pe 
  2. ^  Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
  3. a b c d e f g h i j k l m n o p q r  L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.
  4. a b  Takashi Suzuki, Toshihiko Uno, Guangming Chen, Yuichi Ohashi. Ocular distribution of intravenously administered micafungin in rabbits. Journal of Infection and Chemotherapy. 2008;14(3):204-207. doi:10.1007/s10156-008-0612-5.
  5. a b c d e f g h  T. Felton, P. F. Troke, W. W. Hope. Tissue Penetration of Antifungal Agents. Clinical Microbiology Reviews. 2014;27(1):68-88. doi:10.1128/cmr.00046-13.
  6. ^  Tony H. Huynh, Mark W. Johnson, Grant M. Comer, Douglas N. Fish. Vitreous Penetration of Orally Administered Valacyclovir. American Journal of Ophthalmology. 2008;145(4):682-686. doi:10.1016/j.ajo.2007.11.016.
  7. ^  Luis F. López-Cortés, R. Ruiz-Valderas, M. J. Lucero-Muñoz, E. Cordero, M. T. Pastor-Ramos, J. Marquez. Intravitreal, Retinal, and Central Nervous System Foscarnet Concentrations after Rapid Intravenous Administration to Rabbits. Antimicrobial Agents and Chemotherapy. 2000;44(3):756-759. doi:10.1128/aac.44.3.756-759.2000.